【市場調査レポート】脊椎手術における生物学的製剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Biologics in Spine Surgery Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。脊椎手術における生物学的製剤のグローバル市場インサイト・予測（～2028年） / Global Biologics in Spine Surgery Market Insights, Forecast to 2028 / QY2207E09338資料のイメージです。

• レポートコード：QY2207E09338
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の脊椎手術における生物学的製剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊椎手術における生物学的製剤の世界市場のxxx％を占める「骨移植片」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の脊椎手術における生物学的製剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの脊椎手術における生物学的製剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脊椎手術における生物学的製剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

脊椎手術における生物学的製剤のグローバル主要メーカーには、Medtronic、J &J (DePuy Synthes)、SeaSpine、Xtant Medical、Zimmer Biomet、Stryker、Straumann、Wright Medical Group、Hans Biomed、Arthrexなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

脊椎手術における生物学的製剤市場は、種類と用途によって区分されます。世界の脊椎手術における生物学的製剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
骨移植片、骨移植片代替物、多血小板血漿(PRP)、その他

【用途別セグメント】
病院、診療所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 脊椎手術における生物学的製剤製品概要
- 種類別市場（骨移植片、骨移植片代替物、多血小板血漿(PRP)、その他）
- 用途別市場（病院、診療所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の脊椎手術における生物学的製剤販売量予測2017-2028
- 世界の脊椎手術における生物学的製剤売上予測2017-2028
- 脊椎手術における生物学的製剤の地域別販売量
- 脊椎手術における生物学的製剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脊椎手術における生物学的製剤販売量
- 主要メーカー別脊椎手術における生物学的製剤売上
- 主要メーカー別脊椎手術における生物学的製剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（骨移植片、骨移植片代替物、多血小板血漿(PRP)、その他）
- 脊椎手術における生物学的製剤の種類別販売量
- 脊椎手術における生物学的製剤の種類別売上
- 脊椎手術における生物学的製剤の種類別価格
・用途別市場規模（病院、診療所、その他）
- 脊椎手術における生物学的製剤の用途別販売量
- 脊椎手術における生物学的製剤の用途別売上
- 脊椎手術における生物学的製剤の用途別価格
・北米市場
- 北米の脊椎手術における生物学的製剤市場規模（種類別、用途別）
- 主要国別の脊椎手術における生物学的製剤市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの脊椎手術における生物学的製剤市場規模（種類別、用途別）
- 主要国別の脊椎手術における生物学的製剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の脊椎手術における生物学的製剤市場規模（種類別、用途別）
- 主要国別の脊椎手術における生物学的製剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の脊椎手術における生物学的製剤市場規模（種類別、用途別）
- 主要国別の脊椎手術における生物学的製剤市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの脊椎手術における生物学的製剤市場規模（種類別、用途別）
- 主要国別の脊椎手術における生物学的製剤市場規模（トルコ、サウジアラビア）
・企業情報
Medtronic、J &J (DePuy Synthes)、SeaSpine、Xtant Medical、Zimmer Biomet、Stryker、Straumann、Wright Medical Group、Hans Biomed、Arthrex
・産業チェーン及び販売チャネル分析
- 脊椎手術における生物学的製剤の産業チェーン分析
- 脊椎手術における生物学的製剤の原材料
- 脊椎手術における生物学的製剤の生産プロセス
- 脊椎手術における生物学的製剤の販売及びマーケティング
- 脊椎手術における生物学的製剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脊椎手術における生物学的製剤の産業動向
- 脊椎手術における生物学的製剤のマーケットドライバー
- 脊椎手術における生物学的製剤の課題
- 脊椎手術における生物学的製剤の阻害要因
・主な調査結果

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Market Analysis and Insights: Global Biologics in Spine Surgery Market
Due to the COVID-19 pandemic, the global Biologics in Spine Surgery market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Bone Graft accounting for % of the Biologics in Spine Surgery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Biologics in Spine Surgery market size is valued at US$ million in 2021, while the US and Europe Biologics in Spine Surgery are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Biologics in Spine Surgery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Biologics in Spine Surgery include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Biologics in Spine Surgery Scope and Segment
Biologics in Spine Surgery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biologics in Spine Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Hospital
Clinic
Other
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Biologics in Spine Surgery Product Introduction
1.2 Market by Type
1.2.1 Global Biologics in Spine Surgery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Biologics in Spine Surgery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologics in Spine Surgery Sales Estimates and Forecasts 2017-2028
2.2 Global Biologics in Spine Surgery Revenue Estimates and Forecasts 2017-2028
2.3 Global Biologics in Spine Surgery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biologics in Spine Surgery Sales by Region
2.4.1 Global Biologics in Spine Surgery Sales by Region (2017-2022)
2.4.2 Global Sales Biologics in Spine Surgery by Region (2023-2028)
2.5 Global Biologics in Spine Surgery Revenue by Region
2.5.1 Global Biologics in Spine Surgery Revenue by Region (2017-2022)
2.5.2 Global Biologics in Spine Surgery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biologics in Spine Surgery Sales by Manufacturers
3.1.1 Global Top Biologics in Spine Surgery Manufacturers by Sales (2017-2022)
3.1.2 Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologics in Spine Surgery in 2021
3.2 Global Biologics in Spine Surgery Revenue by Manufacturers
3.2.1 Global Biologics in Spine Surgery Revenue by Manufacturers (2017-2022)
3.2.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biologics in Spine Surgery Revenue in 2021
3.3 Global Biologics in Spine Surgery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biologics in Spine Surgery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologics in Spine Surgery Sales by Type
4.1.1 Global Biologics in Spine Surgery Historical Sales by Type (2017-2022)
4.1.2 Global Biologics in Spine Surgery Forecasted Sales by Type (2023-2028)
4.1.3 Global Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
4.2 Global Biologics in Spine Surgery Revenue by Type
4.2.1 Global Biologics in Spine Surgery Historical Revenue by Type (2017-2022)
4.2.2 Global Biologics in Spine Surgery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
4.3 Global Biologics in Spine Surgery Price by Type
4.3.1 Global Biologics in Spine Surgery Price by Type (2017-2022)
4.3.2 Global Biologics in Spine Surgery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biologics in Spine Surgery Sales by Application
5.1.1 Global Biologics in Spine Surgery Historical Sales by Application (2017-2022)
5.1.2 Global Biologics in Spine Surgery Forecasted Sales by Application (2023-2028)
5.1.3 Global Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
5.2 Global Biologics in Spine Surgery Revenue by Application
5.2.1 Global Biologics in Spine Surgery Historical Revenue by Application (2017-2022)
5.2.2 Global Biologics in Spine Surgery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
5.3 Global Biologics in Spine Surgery Price by Application
5.3.1 Global Biologics in Spine Surgery Price by Application (2017-2022)
5.3.2 Global Biologics in Spine Surgery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biologics in Spine Surgery Market Size by Type
6.1.1 North America Biologics in Spine Surgery Sales by Type (2017-2028)
6.1.2 North America Biologics in Spine Surgery Revenue by Type (2017-2028)
6.2 North America Biologics in Spine Surgery Market Size by Application
6.2.1 North America Biologics in Spine Surgery Sales by Application (2017-2028)
6.2.2 North America Biologics in Spine Surgery Revenue by Application (2017-2028)
6.3 North America Biologics in Spine Surgery Market Size by Country
6.3.1 North America Biologics in Spine Surgery Sales by Country (2017-2028)
6.3.2 North America Biologics in Spine Surgery Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Biologics in Spine Surgery Market Size by Type
7.1.1 Europe Biologics in Spine Surgery Sales by Type (2017-2028)
7.1.2 Europe Biologics in Spine Surgery Revenue by Type (2017-2028)
7.2 Europe Biologics in Spine Surgery Market Size by Application
7.2.1 Europe Biologics in Spine Surgery Sales by Application (2017-2028)
7.2.2 Europe Biologics in Spine Surgery Revenue by Application (2017-2028)
7.3 Europe Biologics in Spine Surgery Market Size by Country
7.3.1 Europe Biologics in Spine Surgery Sales by Country (2017-2028)
7.3.2 Europe Biologics in Spine Surgery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biologics in Spine Surgery Market Size by Type
8.1.1 Asia Pacific Biologics in Spine Surgery Sales by Type (2017-2028)
8.1.2 Asia Pacific Biologics in Spine Surgery Revenue by Type (2017-2028)
8.2 Asia Pacific Biologics in Spine Surgery Market Size by Application
8.2.1 Asia Pacific Biologics in Spine Surgery Sales by Application (2017-2028)
8.2.2 Asia Pacific Biologics in Spine Surgery Revenue by Application (2017-2028)
8.3 Asia Pacific Biologics in Spine Surgery Market Size by Region
8.3.1 Asia Pacific Biologics in Spine Surgery Sales by Region (2017-2028)
8.3.2 Asia Pacific Biologics in Spine Surgery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biologics in Spine Surgery Market Size by Type
9.1.1 Latin America Biologics in Spine Surgery Sales by Type (2017-2028)
9.1.2 Latin America Biologics in Spine Surgery Revenue by Type (2017-2028)
9.2 Latin America Biologics in Spine Surgery Market Size by Application
9.2.1 Latin America Biologics in Spine Surgery Sales by Application (2017-2028)
9.2.2 Latin America Biologics in Spine Surgery Revenue by Application (2017-2028)
9.3 Latin America Biologics in Spine Surgery Market Size by Country
9.3.1 Latin America Biologics in Spine Surgery Sales by Country (2017-2028)
9.3.2 Latin America Biologics in Spine Surgery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biologics in Spine Surgery Market Size by Type
10.1.1 Middle East and Africa Biologics in Spine Surgery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biologics in Spine Surgery Revenue by Type (2017-2028)
10.2 Middle East and Africa Biologics in Spine Surgery Market Size by Application
10.2.1 Middle East and Africa Biologics in Spine Surgery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biologics in Spine Surgery Revenue by Application (2017-2028)
10.3 Middle East and Africa Biologics in Spine Surgery Market Size by Country
10.3.1 Middle East and Africa Biologics in Spine Surgery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biologics in Spine Surgery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 J &J (DePuy Synthes)
11.2.1 J &J (DePuy Synthes) Corporation Information
11.2.2 J &J (DePuy Synthes) Overview
11.2.3 J &J (DePuy Synthes) Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 J &J (DePuy Synthes) Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 J &J (DePuy Synthes) Recent Developments
11.3 SeaSpine
11.3.1 SeaSpine Corporation Information
11.3.2 SeaSpine Overview
11.3.3 SeaSpine Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SeaSpine Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SeaSpine Recent Developments
11.4 Xtant Medical
11.4.1 Xtant Medical Corporation Information
11.4.2 Xtant Medical Overview
11.4.3 Xtant Medical Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Xtant Medical Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Xtant Medical Recent Developments
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Corporation Information
11.5.2 Zimmer Biomet Overview
11.5.3 Zimmer Biomet Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zimmer Biomet Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zimmer Biomet Recent Developments
11.6 Stryker
11.6.1 Stryker Corporation Information
11.6.2 Stryker Overview
11.6.3 Stryker Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Stryker Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Stryker Recent Developments
11.7 Straumann
11.7.1 Straumann Corporation Information
11.7.2 Straumann Overview
11.7.3 Straumann Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Straumann Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Straumann Recent Developments
11.8 Wright Medical Group
11.8.1 Wright Medical Group Corporation Information
11.8.2 Wright Medical Group Overview
11.8.3 Wright Medical Group Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wright Medical Group Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wright Medical Group Recent Developments
11.9 Hans Biomed
11.9.1 Hans Biomed Corporation Information
11.9.2 Hans Biomed Overview
11.9.3 Hans Biomed Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hans Biomed Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hans Biomed Recent Developments
11.10 Arthrex
11.10.1 Arthrex Corporation Information
11.10.2 Arthrex Overview
11.10.3 Arthrex Biologics in Spine Surgery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Arthrex Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Arthrex Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologics in Spine Surgery Industry Chain Analysis
12.2 Biologics in Spine Surgery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologics in Spine Surgery Production Mode & Process
12.4 Biologics in Spine Surgery Sales and Marketing
12.4.1 Biologics in Spine Surgery Sales Channels
12.4.2 Biologics in Spine Surgery Distributors
12.5 Biologics in Spine Surgery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biologics in Spine Surgery Industry Trends
13.2 Biologics in Spine Surgery Market Drivers
13.3 Biologics in Spine Surgery Market Challenges
13.4 Biologics in Spine Surgery Market Restraints
14 Key Findings in The Global Biologics in Spine Surgery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Biologics in Spine Surgery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bone Graft
Table 3. Major Manufacturers of Bone Graft Substitute
Table 4. Major Manufacturers of Platelet Rich Plasma (PRP)
Table 5. Major Manufacturers of Other
Table 6. Global Biologics in Spine Surgery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Biologics in Spine Surgery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Biologics in Spine Surgery Sales by Region (2017-2022) & (Units)
Table 9. Global Biologics in Spine Surgery Sales Market Share by Region (2017-2022)
Table 10. Global Biologics in Spine Surgery Sales by Region (2023-2028) & (Units)
Table 11. Global Biologics in Spine Surgery Sales Market Share by Region (2023-2028)
Table 12. Global Biologics in Spine Surgery Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Biologics in Spine Surgery Revenue Market Share by Region (2017-2022)
Table 14. Global Biologics in Spine Surgery Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Biologics in Spine Surgery Revenue Market Share by Region (2023-2028)
Table 16. Global Biologics in Spine Surgery Sales by Manufacturers (2017-2022) & (Units)
Table 17. Global Biologics in Spine Surgery Sales Share by Manufacturers (2017-2022)
Table 18. Global Biologics in Spine Surgery Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2017-2022)
Table 20. Biologics in Spine Surgery Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Biologics in Spine Surgery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Biologics in Spine Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics in Spine Surgery as of 2021)
Table 23. Biologics in Spine Surgery Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Biologics in Spine Surgery Product Offered
Table 25. Date of Manufacturers Enter into Biologics in Spine Surgery Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 28. Global Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 29. Global Biologics in Spine Surgery Sales Share by Type (2017-2022)
Table 30. Global Biologics in Spine Surgery Sales Share by Type (2023-2028)
Table 31. Global Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Biologics in Spine Surgery Revenue Share by Type (2017-2022)
Table 34. Global Biologics in Spine Surgery Revenue Share by Type (2023-2028)
Table 35. Biologics in Spine Surgery Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Biologics in Spine Surgery Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 38. Global Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 39. Global Biologics in Spine Surgery Sales Share by Application (2017-2022)
Table 40. Global Biologics in Spine Surgery Sales Share by Application (2023-2028)
Table 41. Global Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Biologics in Spine Surgery Revenue Share by Application (2017-2022)
Table 44. Global Biologics in Spine Surgery Revenue Share by Application (2023-2028)
Table 45. Biologics in Spine Surgery Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Biologics in Spine Surgery Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 48. North America Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 49. North America Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 52. North America Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 53. North America Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 56. North America Biologics in Spine Surgery Sales by Country (2023-2028) & (Units)
Table 57. North America Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Biologics in Spine Surgery Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 60. Europe Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 61. Europe Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 64. Europe Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 65. Europe Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 68. Europe Biologics in Spine Surgery Sales by Country (2023-2028) & (Units)
Table 69. Europe Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Biologics in Spine Surgery Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 72. Asia Pacific Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 73. Asia Pacific Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 76. Asia Pacific Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 77. Asia Pacific Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Biologics in Spine Surgery Sales by Region (2017-2022) & (Units)
Table 80. Asia Pacific Biologics in Spine Surgery Sales by Region (2023-2028) & (Units)
Table 81. Asia Pacific Biologics in Spine Surgery Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Biologics in Spine Surgery Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 84. Latin America Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 85. Latin America Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 88. Latin America Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 89. Latin America Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 92. Latin America Biologics in Spine Surgery Sales by Country (2023-2028) & (Units)
Table 93. Latin America Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Biologics in Spine Surgery Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Biologics in Spine Surgery Sales by Type (2017-2022) & (Units)
Table 96. Middle East and Africa Biologics in Spine Surgery Sales by Type (2023-2028) & (Units)
Table 97. Middle East and Africa Biologics in Spine Surgery Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Biologics in Spine Surgery Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Biologics in Spine Surgery Sales by Application (2017-2022) & (Units)
Table 100. Middle East and Africa Biologics in Spine Surgery Sales by Application (2023-2028) & (Units)
Table 101. Middle East and Africa Biologics in Spine Surgery Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Biologics in Spine Surgery Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Biologics in Spine Surgery Sales by Country (2017-2022) & (Units)
Table 104. Middle East and Africa Biologics in Spine Surgery Sales by Country (2023-2028) & (Units)
Table 105. Middle East and Africa Biologics in Spine Surgery Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Biologics in Spine Surgery Revenue by Country (2023-2028) & (US$ Million)
Table 107. Medtronic Corporation Information
Table 108. Medtronic Description and Major Businesses
Table 109. Medtronic Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Medtronic Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Medtronic Recent Developments
Table 112. J &J (DePuy Synthes) Corporation Information
Table 113. J &J (DePuy Synthes) Description and Major Businesses
Table 114. J &J (DePuy Synthes) Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. J &J (DePuy Synthes) Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. J &J (DePuy Synthes) Recent Developments
Table 117. SeaSpine Corporation Information
Table 118. SeaSpine Description and Major Businesses
Table 119. SeaSpine Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. SeaSpine Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. SeaSpine Recent Developments
Table 122. Xtant Medical Corporation Information
Table 123. Xtant Medical Description and Major Businesses
Table 124. Xtant Medical Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Xtant Medical Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Xtant Medical Recent Developments
Table 127. Zimmer Biomet Corporation Information
Table 128. Zimmer Biomet Description and Major Businesses
Table 129. Zimmer Biomet Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Zimmer Biomet Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zimmer Biomet Recent Developments
Table 132. Stryker Corporation Information
Table 133. Stryker Description and Major Businesses
Table 134. Stryker Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Stryker Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Stryker Recent Developments
Table 137. Straumann Corporation Information
Table 138. Straumann Description and Major Businesses
Table 139. Straumann Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Straumann Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Straumann Recent Developments
Table 142. Wright Medical Group Corporation Information
Table 143. Wright Medical Group Description and Major Businesses
Table 144. Wright Medical Group Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Wright Medical Group Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Wright Medical Group Recent Developments
Table 147. Hans Biomed Corporation Information
Table 148. Hans Biomed Description and Major Businesses
Table 149. Hans Biomed Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Hans Biomed Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hans Biomed Recent Developments
Table 152. Arthrex Corporation Information
Table 153. Arthrex Description and Major Businesses
Table 154. Arthrex Biologics in Spine Surgery Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Arthrex Biologics in Spine Surgery Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Arthrex Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Biologics in Spine Surgery Distributors List
Table 160. Biologics in Spine Surgery Customers List
Table 161. Biologics in Spine Surgery Market Trends
Table 162. Biologics in Spine Surgery Market Drivers
Table 163. Biologics in Spine Surgery Market Challenges
Table 164. Biologics in Spine Surgery Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics in Spine Surgery Product Picture
Figure 3. Global Biologics in Spine Surgery Market Share by Type in 2021 & 2028
Figure 3. Bone Graft Product Picture
Figure 4. Bone Graft Substitute Product Picture
Figure 5. Platelet Rich Plasma (PRP) Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biologics in Spine Surgery Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Biologics in Spine Surgery Report Years Considered
Figure 12. Global Biologics in Spine Surgery Sales 2017-2028 (Units)
Figure 13. Global Biologics in Spine Surgery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Biologics in Spine Surgery Revenue 2017-2028 (US$ Million)
Figure 15. Global Biologics in Spine Surgery Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Biologics in Spine Surgery Sales Market Share by Region (2017-2022)
Figure 17. Global Biologics in Spine Surgery Sales Market Share by Region (2023-2028)
Figure 18. North America Biologics in Spine Surgery Sales YoY (2017-2028) & (Units)
Figure 19. North America Biologics in Spine Surgery Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Biologics in Spine Surgery Sales YoY (2017-2028) & (Units)
Figure 21. Europe Biologics in Spine Surgery Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Biologics in Spine Surgery Sales YoY (2017-2028) & (Units)
Figure 23. Asia-Pacific Biologics in Spine Surgery Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Biologics in Spine Surgery Sales YoY (2017-2028) & (Units)
Figure 25. Latin America Biologics in Spine Surgery Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Biologics in Spine Surgery Sales YoY (2017-2028) & (Units)
Figure 27. Middle East & Africa Biologics in Spine Surgery Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Biologics in Spine Surgery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Biologics in Spine Surgery in the World: Market Share by Biologics in Spine Surgery Revenue in 2021
Figure 30. Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 32. Global Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 33. Global Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 34. Global Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 35. North America Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 36. North America Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 37. North America Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 38. North America Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 39. North America Biologics in Spine Surgery Sales Share by Country (2017-2028)
Figure 40. North America Biologics in Spine Surgery Revenue Share by Country (2017-2028)
Figure 41. United States Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 44. Europe Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 45. Europe Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 46. Europe Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 47. Europe Biologics in Spine Surgery Sales Share by Country (2017-2028)
Figure 48. Europe Biologics in Spine Surgery Revenue Share by Country (2017-2028)
Figure 49. Germany Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 50. France Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Biologics in Spine Surgery Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Biologics in Spine Surgery Revenue Share by Region (2017-2028)
Figure 60. China Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 63. India Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 70. Latin America Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 72. Latin America Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Biologics in Spine Surgery Sales Share by Country (2017-2028)
Figure 74. Latin America Biologics in Spine Surgery Revenue Share by Country (2017-2028)
Figure 75. Mexico Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Biologics in Spine Surgery Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Biologics in Spine Surgery Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Biologics in Spine Surgery Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Biologics in Spine Surgery Revenue Share by Country (2017-2028)
Figure 84. Turkey Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Biologics in Spine Surgery Revenue (2017-2028) & (US$ Million)
Figure 87. Biologics in Spine Surgery Value Chain
Figure 88. Biologics in Spine Surgery Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

以下、関連資料のご紹介

脊椎位置決め装置のグローバル市場インサイト・予測（～2028年）

Global Spine Positioning System Market Insights, Forecast to 2028
QY2207E10116 2022年7月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界の脊椎位置決め装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊椎位置決め装置の世...

後弯治療用脊椎ブレースのグローバル市場インサイト・予測（～2028年）

Global Kyphosis Treatment Spine Brace Market Insights, Forecast to 2028
QY2207E09633 2022年7月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界の後弯治療用脊椎ブレースの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に後弯治療用脊椎...

脊椎固定用生物製剤のグローバル市場インサイト・予測（～2028年）

Global Spinal Fusion Biologics Market Insights, Forecast to 2028
QY2207E10113 2022年7月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の脊椎固定用生物製剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊椎固定用生物製剤...

脊椎手術用ロボットシステム＆消耗品のグローバル市場インサイト・予測（～2028年）

Global Spinal Surgery Robotic System and Consumables Market Insights, Forecast to 2028
QY2207E10115 2022年7月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の脊椎手術用ロボットシステム＆消耗品の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脊...

世界の脊椎ポジショニングシステム市場予測（～2028年）：子供用、成人用

Global Spine Positioning System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8410 2022年5月 74Pages
脊椎ポジショニングシステム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供...

脊椎固定用生物製剤のグローバル市場インサイト・予測（～2028年） Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction. Market Analysi…
世界の骨・筋骨格移植片市場予測（～2028年）：皮質細胞移植片、巨大構造移植片、骨誘導性移植片 The Bone and Musculoskeletal Allografts market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
脊椎位置決め装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Spine Positioning System Market Due to the COVID-19 pandemic, the global Spine Positioning System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022…
後弯治療用脊椎ブレースのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Kyphosis Treatment Spine Brace Market Due to the COVID-19 pandemic, the global Kyphosis Treatment Spine Brace market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast…
世界の脊椎ポジショニングシステム市場予測（～2028年）：子供用、成人用 The Spine Positioning System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…